Summit Therapeutics plc (SMMT) PT Lowered to $27 at Needham & Company Apr 12, 2018 07:23AM
Summit Therapeutics Announces Exercise of Underwriters’ Over-Allotment Option Sep 15, 2017 01:31PM
Summit Therapeutics plc (SMMT) Prices 1.46M ADS Offering at $12/Sh Sep 14, 2017 06:23AM
Summit Therapeutics Announces Pricing of Public Offering of 1,459,000 American Depositary Shares Sep 13, 2017 11:03PM
Summit Therapeutics to Present at the Needham Healthcare Conference Mar 30, 2017 07:00AM


Oct 4, 2016 01:38PM Summit Therapeutics (SMMT) PT Raised to $30 at Needham & Company Amid Sarepta Deal
Apr 6, 2016 07:00AM Summit Therapeutics to Present at 15th Annual Needham Healthcare Conference
Oct 2, 2015 06:42AM Needham & Company Reiterates Buy on Summit Therapeutics (SMMT) Following World Muscle Society Meeting
Jun 12, 2015 07:30AM Summit Therapeutics (SMMT) SMT C1100 Fully Enrolled in Trial Phase Ib; Needham & Company Reiterates Buy
Apr 7, 2015 07:00AM Summit to Present at Needham and Company's Annual Healthcare Conference
Mar 30, 2015 06:21AM Needham & Company Starts Summit Therapeutics plc (SMMT) at Buy
Mar 18, 2015 02:15PM Summit Therapeutics Announces Exercise of Over-Allotment Option
Mar 10, 2015 12:45PM Summit Therapeutics Announces Closing of Its U.S. Initial Public Offering
Mar 5, 2015 10:03AM Summit Therapeutics (SMMT) IPO Opens Fractionally Higher